The PKG™ system provides continuous, objective, ambulatory assessment of movement disorder symptoms, such as tremor, dyskinesia and bradykinesia during activities of daily living and in the patient's home environment.
Consisting of an interactive watch that collects movement data, proprietary algorithms and a detailed report, the PKG™ system also correlates the frequency and severity of symptoms with respect to consumption of prescribed medication.
11 April 2018Read More
The Australian Federal Government’s Biomedical Translation Fund has invested $7.7.million in the commercialization of GKC’s Parkinson’s KinetiGraph™ (PKG™) as the company makes inroads to obtaining re…
23 July 2018Leading Parkinson's measurement company Global Kinetics reaches major milestone with issue of US CPTIII CodesRead More
21 August 2018Read More